Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes. A predisposition marker is of particular value in type 2 diabetes since lifestyle plays an important role in the disease. Following diagnosis, those at high-risk might benefit from more aggressive management either through changes in lifestyle or drug treatment. See here for the Compugen press release.
